EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes

Marcello Marchetta, Vincenzo Paragliola, Daniela Benedetto, Stefano Sasso, Maria Crapanzano, Fiorenza Levantesi, Andrea Di Bella, Giorgio Carrillo, Lucio Giuseppe Granata, Gianluca Massaro, Giuseppe Massimo Sangiorgi

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1796-1807

DOI: 10.1002/ccd.70542 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 03.03.2026. Verfasst von Marcello Marchetta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Coronary, Cardiovascular Agents, Coronary Artery Disease, Cardiac Catheters. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐coated balloon (DCB) angioplasty represents a unique drug‐delivery paradigm in which all therapeutic efficacy depends on the first seconds of device‐tissue interaction. Unlike drug‐eluting stents (DES), DCBs must achieve meaningful drug transfer, penetration, and retention during a single, brief inflation. This review provides a mechanistic, bench‐to‐bedside framework linking drug physicochemistry, excipient chemistry, coating engineering, balloon mechanics, and tissue pharmacokinetics to angiographic and clinical outcomes. Paclitaxel‐based DCBs consistently outperform sirolimus‐coated platforms in early drug uptake, intracellular retention, transmural distribution, and late lumen loss. These advantages derive from paclitaxel's extreme lipophilicity, particulate deposition, and high‐affinity microtubule binding, which enable durable antiproliferative activity despite modest absolute transfer. Sirolimus, by contrast, requires an engineered delivery system—crystalline matrices, PLGA micro‐reservoirs, nanoparticle carriers, or pressure‐driven infusion—to compensate for its lower membrane permeability and reversible intracellular binding. Integrating preclinical modeling, coating‐stability studies, optical coherence tomography (OCT) remodeling signatures, randomized trials, and recent meta‐analyses, this review demonstrates that DCB therapy is not a drug‐class effect: technology, not drug load, determines biological behavior. Early transfer efficiency, tissue retention kinetics, depth of penetration, and platform‐specific dissection response fully explain the divergent angiographic patterns observed across devices. Understanding these mechanistic principles is essential for rational device selection and for guiding the next generation of DCB technologies capable of achieving consistent and durable clinical performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angioplasty, Balloon, CoronaryCardiovascular AgentsCoronary Artery DiseaseCardiac CathetersPaclitaxelCoronary AngiographySirolimusCoated Materials, BiocompatibleHumansTreatment OutcomeAnimalsPredictive Value of Tests

Stichwörter der Autor:innen

coatingdrug‐coated balloonexcipientsoutcomespercutaneous coronary interventiontechnology

Substanzen

Cardiovascular AgentsPaclitaxelSirolimusCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • University of Messina, Messina, Italy.

Zitieren

APA

Marchetta, M., Paragliola, V., Benedetto, D., Sasso, S., Crapanzano, M., Levantesi, F., Bella, A. D., Carrillo, G., Granata, L. G., Massaro, G., & Sangiorgi, G. M. (2026). Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes. Catheterization and Cardiovascular Interventions, 107(6), 1796-1807. https://doi.org/10.1002/ccd.70542

Vancouver

Marchetta M, Paragliola V, Benedetto D, Sasso S, Crapanzano M, Levantesi F, et al. Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes. Catheterization and Cardiovascular Interventions. 2026;107(6):1796-1807. doi:10.1002/ccd.70542

BibTeX
@article{Marchetta2026,
  author = {Marchetta, Marcello and Paragliola, Vincenzo and Benedetto, Daniela and Sasso, Stefano and Crapanzano, Maria and Levantesi, Fiorenza and Bella, Andrea Di and Carrillo, Giorgio and Granata, Lucio Giuseppe and Massaro, Gianluca and Sangiorgi, Giuseppe Massimo},
  title = {Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {1796--1807},
  doi = {10.1002/ccd.70542}
}
Kostenlos starten →